These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 29163738)
1. A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan. Negro A; De Marco L; Cesario V; Santi R; Boni MC; Zanelli M J Clin Med Res; 2017 Dec; 9(12):1022-1025. PubMed ID: 29163738 [TBL] [Abstract][Full Text] [Related]
2. Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers. Mandavdhare HS; Sharma V; Prasad KK; Kumar A; Rathi M; Rana SS Intest Res; 2017 Jul; 15(3):419-421. PubMed ID: 28670240 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review. Kamal A; Fain C; Park A; Wang P; Gonzalez-Velez E; Leffler DA; Hutfless SM Gastroenterol Rep (Oxf); 2019 Jun; 7(3):162-167. PubMed ID: 31217979 [TBL] [Abstract][Full Text] [Related]
4. Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan. Odak M; Udongwo N; Alfraji N; Zheng M; Zaidi S J Investig Med High Impact Case Rep; 2021; 9():23247096211037463. PubMed ID: 34378440 [TBL] [Abstract][Full Text] [Related]
5. Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea. Sotiropoulos C; Sakka E; Diamantopoulou G; Theocharis GJ; Thomopoulos KC Cureus; 2021 Aug; 13(8):e17004. PubMed ID: 34540405 [TBL] [Abstract][Full Text] [Related]
6. Small bowel enteropathy associated with olmesartan medoxomil treatment. Galanopoulos M; Varytimiadis L; Tsigaridas A; Karatzas PS; Archavlis E; Viazis N; Vourlakou C; Mantzaris GJ Ann Gastroenterol; 2017; 30(1):131-133. PubMed ID: 28042253 [TBL] [Abstract][Full Text] [Related]
8. Tropical sprue: revisiting an underrecognized disease. Brown IS; Bettington A; Bettington M; Rosty C Am J Surg Pathol; 2014 May; 38(5):666-72. PubMed ID: 24441659 [TBL] [Abstract][Full Text] [Related]
9. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature. Kulai T; Arnason T; MacIntosh D; Igoe J Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852 [TBL] [Abstract][Full Text] [Related]
10. Association of sprue-like enteropathy and angiotensin receptor-1 antagonists. Wenzel RR; Datz C Wien Klin Wochenschr; 2019 Oct; 131(19-20):493-501. PubMed ID: 31471672 [TBL] [Abstract][Full Text] [Related]
11. [Olmesartan therapy and enteropathy: About two cases and review of the literature]. Sadki A; Le Besnerais M; Héron F; Marie I Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111 [TBL] [Abstract][Full Text] [Related]
12. Olmesartan-associated sprue-like enteropathy diagnosed by capsule endoscopy and double balloon endoscopy. Taguchi D; Ibuka T; Arao M; Mizutani T; Ozawa N; Kubota M; Shirakami Y; Shiraki M; Araki H; Shimizu M Clin J Gastroenterol; 2021 Dec; 14(6):1649-1654. PubMed ID: 34480728 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and resolution of olmesartan-associated sprue-like enteropathy confirmed by capsule endoscopy: a case report and literature review. Kodama E; Kawata Y; Yamazaki S; Igarashi T; Kojima Y; Tominaga K; Yokoyama J; Honma T; Terai S Clin J Gastroenterol; 2024 Oct; 17(5):891-898. PubMed ID: 39085738 [TBL] [Abstract][Full Text] [Related]